menu
    • menu
    [{"orgOrder":0,"company":"Avextra","sponsor":"German Pain Association","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"GERMANY","productType":"Controlled Substance","year":"2024","type":"Collaboration","leadProduct":"Tetrahydrocannabinol","moa":"||Cannabinoid CB1 receptor","graph1":"Neurology","graph2":"Undisclosed","graph3":"Avextra","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Avextra \/ German Pain Association","highestDevelopmentStatusID":"1","companyTruncated":"Avextra \/ German Pain Association"},{"orgOrder":0,"company":"Evotec","sponsor":"Bristol Myers Squibb","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"GERMANY","productType":"Cell & Gene Therapy","year":"2020","type":"Collaboration","leadProduct":"Induced Pluripotent Stem Cell","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Evotec","amount2":0.01,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0.01,"dosageForm":"Undisclosed","sponsorNew":"Evotec \/ Bristol Myers Squibb","highestDevelopmentStatusID":"1","companyTruncated":"Evotec \/ Bristol Myers Squibb"},{"orgOrder":0,"company":"IgNova","sponsor":"Scope International AG | Klinar CRO | CenTrial | Pharmasolutions4U | idv Data Analysis","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"GERMANY","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"IGN-ES001","moa":"Unknown","graph1":"Neurology","graph2":"Undisclosed","graph3":"IgNova","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Powder","sponsorNew":"IgNova \/ Scope International AG | Klinar CRO | CenTrial | Pharmasolutions4U | idv Data Analysis","highestDevelopmentStatusID":"1","companyTruncated":"IgNova \/ Scope International AG | Klinar CRO | CenTrial | Pharmasolutions4U | idv Data Analysis"}]

    Find Novel Neurology Drugs in Clinical Development in GERMANY

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Avextra

                            Germany arrow
                            Florida Innovation
                            Not Confirmed

                            Avextra

                            Germany arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetrahydrocannabinol,Cannabidiol

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : German Pain Association

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            German Pain Association and Avextra Join Forces To Launch New Study Ocean

                            Details : The company aims to focus on the clinical advancement of THC , a partial agonist of the CB1 receptor with Cannabidiol, evaluated for chemotherapy-induced neuropathic pain treatment.

                            Product Name : THC:CBD

                            Product Type : Controlled Substance

                            Upfront Cash : Undisclosed

                            January 23, 2024

                            Lead Product(s) : Tetrahydrocannabinol,Cannabidiol

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : German Pain Association

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Evotec

                            Germany arrow
                            Florida Innovation
                            Not Confirmed

                            Evotec

                            Germany arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Induced Pluripotent Stem Cell

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Bristol Myers Squibb

                            Deal Size : $6.0 million

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Evotec and BMS Expand IPSC Collaboration

                            Details : This partnership pursues an innovative approach to identifying and creating novel medicines using several of Evotec's technology technologies in tandem with the human iPSC-based platform.

                            Product Name : Undisclosed

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            January 07, 2020

                            Lead Product(s) : Induced Pluripotent Stem Cell

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Bristol Myers Squibb

                            Deal Size : $6.0 million

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            IgNova

                            Germany arrow
                            Florida Innovation
                            Not Confirmed

                            IgNova

                            Germany arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : IGN-ES001

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Scope International AG | Klinar CRO | CenTrial | Pharmasolutions4U | idv Data Analysis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy and Safety of IGN-ES001 in Chronic Widespread Pain With or Without Fibromyalgia

                            Details : IGN-ES001 is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Chronic Pain.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            February 20, 2017

                            Lead Product(s) : IGN-ES001

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Scope International AG | Klinar CRO | CenTrial | Pharmasolutions4U | idv Data Analysis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth